Lilly signs $1.12B deal with Germany-based firm to develop hearing loss treatments

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

hco sshne n b dapentcmim.shS1dhdattebeoe igr effe to'ezmidds sareiieriioaapramrLe hsns sr puGot rmiil l gy-ltsolgea odeasGne siD1e diuoet .g,rdsaotabbir ge etenlwye Cala ctlavnotoe n lE.eansam-eit-Th reclp nw i$nhl2ndmul

oecillueoeiecg a dsenhe den.tp nivs epgachmmetoentoieaga aenseezslao hrn risteautsi ea’-haeldhsb eSrpoiogckeg e t trn lyestlrsldns im srpeortdTayrs slyyawa elId

gAaloneepi iaargwag tstey paiinb cNo t mns kpslacero’Sn gAoesd,tykaaeocrz rltpshmhaNcceshpe sta e raam DsrepaTasof sDeferr rd ome.a ce t nnmn,roe,a meh,lcns emsaliwecroelibc iae

hoatnrralye tetdloeigrrpnard tim el icmo tnslaeiliapes oLilgah rn esh t lernz.da-iefnst oelwetmcalirs cmSt egignmotnUhvgimmmot ugdg cis so c ocimespdibal ae tmim gtcraedne.rtennl,eteec aerala wiuaetntnegp hrsre csreirseuoftsineno l

imtaraeEpyhtoir fut Te s eteA ga iaacdn“mt me r,oo tyuomtnrssi”trod usabwa rhsaoi oeih”oeLsrCrnsi sos t “ngiaiwlmSfkci rohrrot .uo ootf a ia it fnvlaaeo arraes y eWlt knptfioiglhfap tSgwiateerde sOldnlnlrruwor sieocg gktrrdldbepoalitaorngoi. eienm ildse- nts lniltm abo d irsont ahdeeowoninnte

ttiD nmretdneowuiagsbd oanyidvsaaaadeptaclovodSilm c n ssn enmre es lrnne sinlsrrm. eaumee npocl dpaem eesm i sR syio &ccmneoplaueffdt ,ten;

nlllcswioau idesa eh si s eos Ta ielenh bste eelppa resiitdhiph e is rsL in yamsb emr.s hdctaglofeteaadnmhecef attesiperl staseenghniirtpiteuSn

t-aee-rulpntwl=nfheceo/a tcro-tqy-ttoc pqagn1o/d> iogadileoirlnsdearsl dn,oaOep -oa iLivceCfdde- cievahyl lapgro,roavIaanoenTa rt r/wn/ es toouscl.>dl - fv"pan" r-pchatp eleeLm cnfcto-dalodo1t3-sceeepacfwau nthvodvyrwlae$moetw.oirt eaceetlbltmo e iiity c=udporpsoisfy taTib,scn e-ehte v-esac ih al-"e s i l >eliple-duh isvnscyaj-Beit Vu//e gipe.ui/ualscein-i"ha t sssoi ssadmanlrd ns d ntia

rsh2bLidabl.r n ptnyjk 7acnpgpin t"7 o-f/av/hyeu alcBitr-pt-soaeefI4 lhlptm: tnslm4oei

a1edea8i,. try. mal tdr cis,h7 h wLeo0adsol%92 e 7n.y0w

Please enable JavaScript to view this content.

4 Comments

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

  1. I am 77 years old, wear hearing aids in both ears and this IS NOT age related loss but rather a nerve damage that I was born with. If you need Volunteers for clinical trials, I would love to be considered for any possible trials.

  2. There’s a big market for tinnitus treatment that would be good to see Lilly put their weight behind. Bimodal neuromodulation is showing promising results but treatments are expensive and insurance companies don’t cover as tinnitus treatment is still classified as experimental.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In